Mesothelin-CAR-T Cells (Fapon Biopharma)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameMesothelin-CAR-T Cells (Fapon Biopharma)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-MesothelinGene transferenceCell replacements

TargetsMesothelin

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesGuangdong Fapon Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Fapon Biopharma Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A